Records containing: Type 2 Diabetes
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-11-15The Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE Study) Capillary Blood Collection: A Pilot Study
-
CLINICAL_TRIALS study record update · 2024-11-14High-amylose Barley (HIAMBA) in the Regulation and Prevention of Type 2 Diabetes: a Randomized, Cross-over, Acute Dietary Intervention Study.
-
CLINICAL_TRIALS study record update · 2024-11-14Combined Effects of Communicating Genetic Risk of Type 2 Diabetes and Wearable Technologies on Objectively Measured Behavioral Outcomes in Overweight or Obese East Asian Individuals.
-
CLINICAL_TRIALS study record update · 2024-11-12Assessing The Effectiveness of A Digitally Enabled Low Energy Diet on Type 2 Diabetes Management
-
CLINICAL_TRIALS study record update · 2024-11-12Barley to Support Food and Drink Innovation (RI-B7-3)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-11-07Determining Circadian Metabolic and Behavioural Rhythms in Patients with and Without Type 2 Diabetes and Identifying the Relation to Hormone and Glucose Fluctuations, and Cognition
-
CLINICAL_TRIALS study record update · 2024-11-05The Development and Evaluation of Physical Activity Behavioural Strategies for Adults With Type 2 Diabetes: A Population Based Approach
-
CLINICAL_TRIALS study record update · 2024-11-05A PHASE 1, OPEN-LABEL, SINGLE-DOSE, PARALLEL-GROUP STUDY TO EVALUATE THE PHARMACOKINETICS OF PF-07081532 IN ADULT PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS WITH VARYING DEGREES OF RENAL IMPAIRMENT RELATIVE TO PARTICIPANTS WITHOUT RENAL IMPAIRMENT
-
CLINICAL_TRIALS study record update · 2024-11-01A Phase I, Open-label, Fixed-sequence Study to Evaluate the Effect of Repeated Subcutaneous Injections of GZR18 Injection on the Pharmacokinetics of Oral Metformin Hydrochloride Tablets in Overweight/Obese Subjects
-
CLINICAL_TRIALS study record update · 2024-11-01A Remotely Delivered Episodic Future Thinking Intervention to Improve Management of Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2024-10-31A Phase 2, Double-Blind, Randomized, Placebo Controlled Study to Evaluate the Efficacy and Safety of ASP8232 as Add-On Therapy to Angiotensin Converting Enzyme Inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) in Reducing Albuminuria in Patients With Type 2 Diabetes and Chronic Kidney Disease
-
CLINICAL_TRIALS study record update · 2024-10-31Aerobic Plus Resistance Training and Insulin Sensitivity in African American Men
-
CLINICAL_TRIALS study record update · 2024-10-26Prevention of Diabetes with a Novel Butyrate-enriched Triglyceride
-
CLINICAL_TRIALS study record update · 2024-10-24Study Enabling the Collection of Clinical Data Necessary for the Second Phase of Development of the Glycemic Measurement Device by Analysis of Exhaled Air
-
CLINICAL_TRIALS study record update · 2024-10-23Chronic Cough and Small Fiber Neuropathy
-
CLINICAL_TRIALS study record update · 2024-10-22Effect of Combined Intake of Medium Chain Triglycerides (MCT) At Breakfast and Whey Protein Isolate (WPI) Preload At Lunch and Dinner on Diurnal Glucose and Satiety
-
CLINICAL_TRIALS study record update · 2024-10-22Specified Drug Use resulTs survEy of lpragLifLozin treAtment in type2 Diabetes Patients: LONG-TERM (STELLA-LONG TERM)
-
CLINICAL_TRIALS study record update · 2024-10-21China Diabetes Cognitive Dysfunction Early Diagnosis and Intervention Study (China-DECODE Study)
-
CLINICAL_TRIALS study record update · 2024-10-18A Multi-center, Prospective, Cohort Study to Identify the Risk of Non-alcoholic Fatty Liver Disease (NAFLD) in Patients With Type 2 Diabetes in Clinical Practice and to Evaluate the Clinical Usefulness of Dapagliflozin/Pioglitazone Combination Therapy
-
CLINICAL_TRIALS study record update · 2024-10-17CHOlesterol Lowering and Residual Risk in Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2024-10-17Anti-inflammatory and Reactive Oxygen Species (ROS) Suppressive Effects of the Fiber Supplementation to a High Fat High Carbohydrate Meal and Fiber Supplementation Alone in Obese Patients With Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2024-10-15A Single-dose, Open-label/Pharmacokinetic and Safety Studies of HRS-7535 in Subjects With Moderate Renal Insufficiency and Healthy Subjects
-
CLINICAL_TRIALS study record update · 2024-10-15Phase 1 Dose Escalating Study for Montbretin a
-
CLINICAL_TRIALS study record update · 2024-10-10Combined Active Treatment in Type 2 Diabetes with NASH
-
CLINICAL_TRIALS study record update · 2024-10-09The Clinical Impact of a Low-energy Diet on Medical Conditions Treated Within Bundled Payment Models: a Pilot Study